Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
CryoPort Analyst Ratings and Price Targets | NASDAQ:CYRX | Benzinga
CryoPort Inc has a consensus price target of $11.3 based on the ratings of 11 analysts. The high is $17 issued by Stephens & Co. on March 13, 2024. The low is $7 issued by Morgan Stanley on May 5, 2025. The 3 most-recent analyst ratings were released by Needham, Morgan Stanley, and Needham on May 8, 2025, May 5, 2025, and April 16, 2025, respectively. With an average price target of $9.67 between Needham, Morgan Stanley, and Needham, there's an implied 58.73% upside for CryoPort Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Needham
Morgan Stanley
Guggenheim
Roth MKM
UBS
1calculated from analyst ratings
Analyst Ratings for CryoPort
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/08/2025 | Buy Now | 80.62% | Needham | David Saxon54% | $11 → $11 | Reiterates | Buy → Buy | Get Alert |
| 05/05/2025 | Buy Now | 14.94% | Morgan Stanley | Tejas Savant30% | $8 → $7 | Maintains | Equal-Weight | Get Alert |
| 04/16/2025 | Buy Now | 80.62% | Needham | David Saxon54% | $11 → $11 | Reiterates | Buy → Buy | Get Alert |
| 04/16/2025 | Buy Now | 64.2% | Guggenheim | Subbu Nambi45% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 04/10/2025 | Buy Now | 80.62% | Needham | David Saxon54% | $11 → $11 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2025 | Buy Now | 146.31% | Roth MKM | Richard Baldry39% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2025 | Buy Now | 80.62% | UBS | John Sourbeer32% | $10 → $11 | Maintains | Buy | Get Alert |
| 04/01/2025 | Buy Now | 80.62% | Needham | David Saxon54% | $11 → $11 | Reiterates | Buy → Buy | Get Alert |
| 03/31/2025 | Buy Now | 80.62% | Needham | David Saxon54% | $11 → $11 | Reiterates | Buy → Buy | Get Alert |
| 03/24/2025 | Buy Now | 64.2% | UBS | John Sourbeer32% | → $10 | Upgrade | Neutral → Buy | Get Alert |
| 03/05/2025 | Buy Now | 80.62% | Needham | David Saxon54% | $11 → $11 | Reiterates | Buy → Buy | Get Alert |
| 01/17/2025 | Buy Now | 80.62% | Needham | David Saxon54% | $11 → $11 | Reiterates | Buy → Buy | Get Alert |
| 11/08/2024 | Buy Now | 146.31% | Roth MKM | Richard Baldry39% | $18 → $15 | Maintains | Buy | Get Alert |
| 10/18/2024 | Buy Now | 47.78% | UBS | Dan Leonard52% | $7 → $9 | Maintains | Neutral | Get Alert |
| 08/07/2024 | Buy Now | 14.94% | UBS | Dan Leonard52% | $17 → $7 | Maintains | Neutral | Get Alert |
| 08/07/2024 | Buy Now | 31.36% | Jefferies | Matthew Stanton22% | $20 → $8 | Downgrade | Buy → Hold | Get Alert |
| 08/07/2024 | Buy Now | 80.62% | Needham | David Saxon54% | $18 → $11 | Maintains | Buy | Get Alert |
| 07/31/2024 | Buy Now | 146.31% | B. Riley Securities | Yuan Zhi29% | $19 → $15 | Upgrade | Neutral → Buy | Get Alert |
| 05/08/2024 | Buy Now | 195.57% | Needham | David Saxon54% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 05/03/2024 | Buy Now | 211.99% | B. Riley Securities | Yuan Zhi29% | $22 → $19 | Downgrade | Buy → Neutral | Get Alert |
| 04/04/2024 | Buy Now | 244.83% | Jefferies | Matthew Stanton22% | $17 → $21 | Assumes | → Buy | Get Alert |
| 03/15/2024 | Buy Now | 179.15% | UBS | John Sourbeer32% | $14.5 → $17 | Maintains | Neutral | Get Alert |
| 03/13/2024 | Buy Now | 179.15% | Stephens & Co. | Jacob Johnson7% | $17 → $17 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 03/13/2024 | Buy Now | 195.57% | Needham | David Saxon54% | $19 → $18 | Maintains | Buy | Get Alert |
| 01/18/2024 | Buy Now | 211.99% | Needham | David Saxon54% | $18 → $19 | Maintains | Buy | Get Alert |
| 08/17/2023 | Buy Now | 162.73% | Morgan Stanley | Tejas Savant30% | → $16 | Initiates | → Equal-Weight | Get Alert |
| 08/10/2023 | Buy Now | 244.83% | Needham | David Saxon54% | $30 → $21 | Maintains | Buy | Get Alert |
| 07/18/2023 | Buy Now | 179.15% | UBS | John Sourbeer32% | $28 → $17 | Downgrade | Buy → Neutral | Get Alert |
| 07/17/2023 | Buy Now | 146.31% | Stephens & Co. | Jacob Johnson7% | $26 → $15 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/17/2023 | Buy Now | — | Keybanc | Paul Knight54% | — | Downgrade | Overweight → Sector Weight | Get Alert |
| 07/13/2023 | Buy Now | 310.51% | Roth MKM | Richard Baldry39% | $40 → $25 | Maintains | Buy | Get Alert |
| 07/13/2023 | Buy Now | 261.25% | B. Riley Securities | Yuan Zhi29% | $30 → $22 | Maintains | Buy | Get Alert |
| 07/13/2023 | Buy Now | 326.93% | Stephens & Co. | Jacob Johnson7% | → $26 | Reiterates | Overweight → Overweight | Get Alert |
| 07/13/2023 | Buy Now | 64.2% | SVB Leerink | Puneet Souda41% | $30 → $10 | Downgrade | Outperform → Market Perform | Get Alert |
| 07/13/2023 | Buy Now | 392.61% | Needham | David Saxon54% | → $30 | Reiterates | Buy → Buy | Get Alert |
| 06/06/2023 | Buy Now | 359.77% | UBS | John Sourbeer32% | $26 → $28 | Maintains | Buy | Get Alert |
| 05/05/2023 | Buy Now | 392.61% | Needham | David Saxon54% | → $30 | Reinstates | → Buy | Get Alert |
| 04/21/2023 | Buy Now | 392.61% | Needham | David Saxon54% | → $30 | Reiterates | → Buy | Get Alert |
| 02/24/2023 | Buy Now | 392.61% | Needham | David Saxon54% | $28 → $30 | Maintains | Buy | Get Alert |
| 12/08/2022 | Buy Now | 392.61% | Keybanc | Paul Knight54% | $40 → $30 | Maintains | Overweight | Get Alert |
| 11/16/2022 | Buy Now | 392.61% | B. Riley Securities | Yuan Zhi29% | $55 → $30 | Maintains | Buy | Get Alert |
| 11/04/2022 | Buy Now | 359.77% | SVB Leerink | Puneet Souda41% | $45 → $28 | Maintains | Outperform | Get Alert |
| 11/04/2022 | Buy Now | 359.77% | Needham | David Saxon54% | $49 → $28 | Maintains | Buy | Get Alert |
| 11/04/2022 | Buy Now | 556.81% | Keybanc | Paul Knight54% | $52 → $40 | Maintains | Overweight | Get Alert |
| 07/12/2022 | Buy Now | 589.66% | Needham | David Saxon54% | $41 → $42 | Maintains | Buy | Get Alert |
FAQ
What is the target price for CryoPort (CYRX) stock?
The latest price target for CryoPort (NASDAQ:CYRX) was reported by Needham on May 8, 2025. The analyst firm set a price target for $11.00 expecting CYRX to rise to within 12 months (a possible 80.62% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CryoPort (CYRX)?
The latest analyst rating for CryoPort (NASDAQ:CYRX) was provided by Needham, and CryoPort reiterated their buy rating.
When was the last upgrade for CryoPort (CYRX)?
The last upgrade for CryoPort Inc happened on March 24, 2025 when UBS raised their price target to $10. UBS previously had a neutral for CryoPort Inc.
When was the last downgrade for CryoPort (CYRX)?
The last downgrade for CryoPort Inc happened on August 7, 2024 when Jefferies changed their price target from $20 to $8 for CryoPort Inc.
When is the next analyst rating going to be posted or updated for CryoPort (CYRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CryoPort, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CryoPort was filed on May 8, 2025 so you should expect the next rating to be made available sometime around May 8, 2026.
Is the Analyst Rating CryoPort (CYRX) correct?
While ratings are subjective and will change, the latest CryoPort (CYRX) rating was a reiterated with a price target of $11.00 to $11.00. The current price CryoPort (CYRX) is trading at is $6.09, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
